BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1581494)

  • 1. A rank-based mixed model approach to multisite clinical trials.
    Boos DD; Brownie C
    Biometrics; 1992 Mar; 48(1):61-72. PubMed ID: 1581494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probability models and computational models for ANOVA in multicenter clinical trials.
    Permutt T
    J Biopharm Stat; 2003 Aug; 13(3):495-505. PubMed ID: 12921396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statistical analysis of community-based studies -- presentation and comparison of possible solutions with reference to statistical meta-analytic methods].
    Twardella D; Bruckner T; Blettner M
    Gesundheitswesen; 2005 Jan; 67(1):48-55. PubMed ID: 15672306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
    Davis CS; Chung Y
    Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing bivariate repeated measures for discrete and continuous outcome variables.
    Rochon J
    Biometrics; 1996 Jun; 52(2):740-50. PubMed ID: 8672710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of rank-based procedures for multicenter clinical trials.
    Rashid MM; McKean JW; Kloke JD
    J Biopharm Stat; 2013; 23(6):1207-27. PubMed ID: 24138428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model.
    Legrand C; Ducrocq V; Janssen P; Sylvester R; Duchateau L
    Stat Med; 2005 Dec; 24(24):3789-804. PubMed ID: 16320274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-rank scale-invariant tensor product smooths for generalized additive mixed models.
    Wood SN
    Biometrics; 2006 Dec; 62(4):1025-36. PubMed ID: 17156276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of multi-centre trials with binary response.
    Dragalin V; Fedorov V
    Stat Med; 2006 Aug; 25(16):2701-19. PubMed ID: 16252268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized variance component models for clustered categorical response variables.
    Miller ME; Landis JR
    Biometrics; 1991 Mar; 47(1):33-44. PubMed ID: 2049507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinear mixed effects models for repeated measures data.
    Lindstrom ML; Bates DM
    Biometrics; 1990 Sep; 46(3):673-87. PubMed ID: 2242409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed effects logistic regression models for longitudinal binary response data with informative drop-out.
    Ten Have TR; Kunselman AR; Pulkstenis EP; Landis JR
    Biometrics; 1998 Mar; 54(1):367-83. PubMed ID: 9544529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed-effects model for categorical data.
    Beitler PJ; Landis JR
    Biometrics; 1985 Dec; 41(4):991-1000. PubMed ID: 3830263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Meta-analysis in multi-center random controlled clinical trials].
    Ou AH; Lao YR; Li XQ; Huang Y; He YT; Huang PX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):290-3. PubMed ID: 15941541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random effects probit and logistic regression models for three-level data.
    Gibbons RD; Hedeker D
    Biometrics; 1997 Dec; 53(4):1527-37. PubMed ID: 9423267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A boosting approach to flexible semiparametric mixed models.
    Tutz G; Reithinger F
    Stat Med; 2007 Jun; 26(14):2872-900. PubMed ID: 17133647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline and treatment effect heterogeneity for survival times between centers using a random effects accelerated failure time model with flexible error distribution.
    Komárek A; Lesaffre E; Legrand C
    Stat Med; 2007 Dec; 26(30):5457-72. PubMed ID: 17910009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error.
    Knoke JD
    Biometrics; 1991 Jun; 47(2):523-33. PubMed ID: 1912259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling clustered survival data from multicentre clinical trials.
    Glidden DV; Vittinghoff E
    Stat Med; 2004 Feb; 23(3):369-88. PubMed ID: 14748034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.